Baldessari, Cinzia
 Distribuzione geografica
Continente #
NA - Nord America 1.640
AS - Asia 1.378
EU - Europa 708
SA - Sud America 193
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 3.955
Nazione #
US - Stati Uniti d'America 1.598
SG - Singapore 417
CN - Cina 364
IT - Italia 197
VN - Vietnam 185
HK - Hong Kong 181
BR - Brasile 132
GB - Regno Unito 104
DE - Germania 83
SE - Svezia 79
FI - Finlandia 62
KR - Corea 49
RU - Federazione Russa 49
IN - India 42
FR - Francia 39
ID - Indonesia 29
PL - Polonia 19
BD - Bangladesh 17
CA - Canada 17
AR - Argentina 15
ZA - Sudafrica 14
CL - Cile 13
JP - Giappone 13
NL - Olanda 13
IQ - Iraq 12
MX - Messico 12
VE - Venezuela 12
AT - Austria 11
BG - Bulgaria 11
TR - Turchia 8
ES - Italia 6
UA - Ucraina 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
JO - Giordania 5
LT - Lituania 5
PE - Perù 5
PH - Filippine 5
PK - Pakistan 5
UY - Uruguay 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
QA - Qatar 4
TN - Tunisia 4
BE - Belgio 3
CR - Costa Rica 3
IL - Israele 3
KZ - Kazakistan 3
MA - Marocco 3
MY - Malesia 3
NP - Nepal 3
SN - Senegal 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CO - Colombia 2
EG - Egitto 2
IE - Irlanda 2
JM - Giamaica 2
KE - Kenya 2
KH - Cambogia 2
LB - Libano 2
MN - Mongolia 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
CG - Congo 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
Totale 3.955
Città #
Singapore 262
Ashburn 254
Santa Clara 184
Hong Kong 175
Hefei 146
Chandler 126
San Jose 107
Fairfield 97
Ho Chi Minh City 64
Nyköping 59
Helsinki 57
London 55
Beijing 54
Woodbridge 50
Seoul 48
Los Angeles 40
Seattle 39
Hanoi 38
Council Bluffs 37
New York 36
Houston 33
Wilmington 28
Chicago 25
Munich 25
Dallas 24
Ann Arbor 23
Cambridge 23
San Diego 21
Shanghai 21
Lauterbourg 19
Bologna 18
Jakarta 17
São Paulo 16
Buffalo 15
Southend 15
The Dalles 15
Modena 14
Bremen 13
Moscow 12
Princeton 12
Biên Hòa 11
Milan 11
Warsaw 11
Brooklyn 10
Denver 10
Frankfurt am Main 10
Tokyo 10
Atlanta 9
Salt Lake City 9
Stockholm 9
Chennai 8
Guangzhou 8
Gurugram 8
Kent 8
Orem 8
Sofia 8
Amsterdam 7
Da Nang 7
Dearborn 7
Düsseldorf 7
Johannesburg 7
Mexico City 7
Montreal 7
New Delhi 7
Nuremberg 7
Rio de Janeiro 7
Santiago 7
Toronto 7
Vienna 7
Falls Church 6
Reggio Calabria 6
Rimini 6
Tashkent 6
Caracas 5
Elk Grove Village 5
Haiphong 5
Hillsboro 5
Mumbai 5
Padova 5
Phoenix 5
Redondo Beach 5
Reggio Emilia 5
Brasília 4
Carpi 4
Charlotte 4
Dhaka 4
Dong Ket 4
Francavilla al Mare 4
Gdansk 4
Ha Long 4
Jacksonville 4
Lappeenranta 4
Naples 4
Palermo 4
Poplar 4
Portsmouth 4
Rome 4
Amman 3
Baghdad 3
Baltimore 3
Totale 2.694
Nome #
Body composition and inflammation impact in non-small cell lung cancer patients treated by first-line immunotherapy 337
Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma 309
Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis 300
Treating cancer with immunotherapy in HIV-positive patients: A challenging reality 227
Myocarditis and diaphragmatic rhabdomyolysis with respiratory failure in a patient with metastatic melanoma treated with Nivolumab 199
Long survival of a young patient with Xp11.2 translocation metastatic clear cell renal carcinoma: case report 182
IDH signalling pathway in cholangiocarcinoma: From biological rationale to therapeutic targeting 179
Exceptional response to lurbinectedin and irinotecan in BRCA-mutated platinum-resistant ovarian cancer patient: a case report 179
Long progression-free survival with cabozantinib in a heavily pretreated patient with metastatic renal cell carcinoma: a case report 173
Cemiplimab- and nivolumab-induced myasthenia gravis: two clinical cases 173
Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma 159
Homologous Recombination Repair Deficiency in Metastatic Prostate Cancer: New Therapeutic Opportunities 157
Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres 156
New Advances in Metastatic Urothelial Cancer: A Narrative Review on Recent Developments and Future Perspectives 150
Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer 147
Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced prostate cancer: a case report 141
Cerebellar metastasis of ovarian cancer: a case report 140
Cabozantinib and nivolumab as first-line treatment in advanced renal cell carcinoma 138
De Novo Metastatic Prostate Cancer: Are We Moving toward a Personalized Treatment? 136
Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications 136
Immunotherapy in urothelial cancer: current status and future directions 117
Sertoli cell tumor associated with ovarian sex cord tumor withannular tubules in a patient with 46 XY disorder of sex developmentand 9p24.3 deletion, case report 80
A Novel Molecular Profile of Hormone-Sensitive Prostate Cancer Defines High Risk Patients 71
Totale 3.986
Categoria #
all - tutte 16.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 0 0 0 0 28 11 28
2021/2022197 13 2 0 11 8 31 5 8 24 23 33 39
2022/2023344 45 50 26 28 39 38 14 50 25 5 10 14
2023/2024235 8 16 18 24 36 25 21 25 10 11 13 28
2024/2025862 28 3 19 54 118 107 89 72 114 45 82 131
2025/20262.020 181 104 192 280 295 143 277 123 199 226 0 0
Totale 3.986